Related Experiment Video
Updated: Oct 16, 2025

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
Dynamic m6A mRNA Methylation Reveals the Role of METTL3/14-m6A-MNK2-ERK Signaling Axis in Skeletal Muscle
Shu-Juan Xie1,2, Hang Lei2, Bing Yang3
1Vaccine Research Institute of Sun Yat-sen University, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Abstract:
N6-methyladenosine (m6A) RNA methylation has emerged as an important factor in various biological processes by regulating gene expression. However, the dynamic profile, function and underlying molecular mechanism of m6A modification during skeletal myogenesis remain elusive. Here, we report that members of the m6A core methyltransferase complex, METTL3 and METTL14, are downregulated during skeletal muscle development. Overexpression of either METTL3 or METTL14 dramatically blocks myotubes formation. Correspondingly, knockdown of METTL3 or METTL14 accelerates the differentiation of skeletal muscle cells. Genome-wide transcriptome analysis suggests ERK/MAPK is the downstream signaling pathway that is regulated to the greatest extent by METTL3/METTL14. Indeed, METTL3/METTL14 expression facilitates ERK/MAPK signaling. Via MeRIP-seq, we found that MNK2, a critical regulator of ERK/MAPK signaling, is m6A modified and is a direct target of METTL3/METTL14. We further revealed that YTHDF1 is a potential reader of m6A on MNK2, regulating MNK2 protein levels without affecting mRNA levels. Furthermore, we discovered that METTL3/14-MNK2 axis was up-regulated notably after acute skeletal muscle injury. Collectively, our studies revealed that the m6A writers METTL3/METTL14 and the m6A reader YTHDF1 orchestrate MNK2 expression posttranscriptionally and thus control ERK signaling, which is required for the maintenance of muscle myogenesis and may contribute to regeneration.
Insights
N6-methyladenosine (m6A) RNA methylation is crucial for skeletal muscle development. METTL3/METTL14 regulate muscle cell differentiation by controlling MNK2 and ERK signaling, impacting muscle regeneration.
Area of Science:
- Epigenetics
- Molecular Biology
- Skeletal Muscle Physiology
Background:
- N6-methyladenosine (m6A) RNA methylation regulates gene expression in diverse biological processes.
- The role of m6A in skeletal myogenesis is not well understood.
Purpose of the Study:
- Investigate the dynamic profile, function, and molecular mechanisms of m6A modification during skeletal myogenesis.
- Elucidate the role of m6A writers METTL3/METTL14 and reader YTHDF1 in muscle development and regeneration.
Main Methods:
- Analysis of METTL3 and METTL14 expression during skeletal muscle development.
- Overexpression and knockdown studies of METTL3 and METTL14 in skeletal muscle cells.
- Genome-wide transcriptome analysis and MeRIP-seq.
- Western blotting to assess protein levels.
Main Results:
- METTL3 and METTL14 expression decreases during skeletal muscle development.
- METTL3/METTL14 overexpression inhibits myogenesis, while knockdown accelerates differentiation.
- The ERK/MAPK signaling pathway is a key downstream target regulated by METTL3/METTL14.
- MNK2, a regulator of ERK/MAPK, is m6A modified by METTL3/METTL14 and its protein levels are regulated by YTHDF1.
- The METTL3/14-MNK2 axis is upregulated after skeletal muscle injury.
Conclusions:
- METTL3/METTL14 and YTHDF1 orchestrate MNK2 expression posttranscriptionally, controlling ERK signaling.
- This m6A-mediated pathway is essential for skeletal myogenesis maintenance and contributes to muscle regeneration.
Related Concept Videos
Master Transcription Regulators
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
PI3K/mTOR/AKT Signaling Pathway
Satellite Stem Cells and Muscular Dystrophy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades

